Panel Discussion: Developing, Commercializing & Delivering Dry AMD Therapeutics into the Hands of Physicians & Patients in Need

Time: 3:30 pm
day: Day Two


During this discussion we will summarise the learnings of the meeting by addressing:

What are the strengths of existing dry AMD
therapeutic approaches?

What is the marketing opportunity versus unmet
patient clinical need that needs to be addressed by
emerging therapeutic approaches for dry AMD? As
we are working outside of an orphan disease state,
what will the cost of treatment look like and what will
the patient share of costs be?